SYMPHORNA
LIVE

Serial Number

99379564

Owner

Uncommon Bio Limited

Attorney

Andrew D. Price

Filing Date

Sep 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SYMPHORNA Trademark

Serial Number: 99379564

SYMPHORNA is a trademark filed by Uncommon Bio Limited on September 8, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Uncommon Bio Limited (8 trademarks)

Unit 2 Cambridge Technopark,

Entity Type: 99

Trademark Details

Filing Date

September 8, 2025

Registration Date

Not Registered

Published for Opposition

September 1, 2026

Goods & Services

Chemical substances and organic compounds for the manufacture of pharmaceuticals and dietary supplements and for use in the biotechnology industry, namely nucleotides, nucleosides, and enzymes for use in nucleic acid synthesis; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; preservatives for use in the pharmaceutical and food industries; nucleic acids, RNA, and mRNA for laboratory use, namely synthetic mRNA constructs and small interfering RNA (siRNA) molecules; plasmids and gene vectors for research purposes; lipids and lipid-based substances for use in drug delivery systems; biologically active molecules for use in biotechnology; biochemical catalysts; culture media and reagents for growing cells and tissues in laboratory conditions, namely cell culture media, buffers, and growth reagents; plant extracts for use in the manufacture of pharmaceuticals, dietary supplements and in the biotechnology industry; vitamins, minerals, and proteins for use in food and supplement manufacture; lipids and lipid-based formulations for industrial use in pharmaceutical and biotechnological manufacturing; fatty substances and carrier compounds for use in the production of therapeutic and nutritional products, namely lipid nanoparticles and polymer-based carrier compounds; lipids for use in the manufacture of pharmaceuticals, dietary supplements and in the biotechnology industry

Sanitary preparations for medical use; RNA-based vaccines; therapeutic vaccines; oligonucleotide-based therapeutics, namely antisense oligonucleotide therapeutics; gene therapy preparations, namely viral vector-based gene therapy preparations; CRISPR-based therapeutics and genome editing agents, namely CRISPR-Cas9 gene editing preparations; immunotherapeutic agents, namely monoclonal antibody-based immunotherapeutic agents; therapeutic preparations for modulation of immune responses; personalised medicine formulations, namely patient-specific RNA-based therapeutic formulations; cell-based pharmaceutical preparations, namely engineered cell therapy preparations; in vivo cell therapy preparations in the form of pharmaceutical compositions, namely in vivo reprogrammed cell therapy compositions; ex vivo cell therapy preparations in the form of pharmaceutical compositions comprising modified or unmodified cells for administration to patients; regenerative and tissue-based therapeutic products, namely tissue regeneration formulations for organ repair; pharmaceutical preparations incorporating lipid nanoparticles or other delivery systems, namely lipid nanoparticle-encapsulated RNA therapeutics; diagnostic reagents and test kits comprising antibodies, primers, and detection reagents for medical use; diagnostic preparations for veterinary purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements; nutritional supplements; biological and pharmaceutical preparations for medical and veterinary use, namely RNA-based veterinary therapeutics

Custom manufacture of pharmaceuticals, biopharmaceuticals, gene therapy products, dietary supplements, and therapeutic delivery systems; manufacturing of personalised medicine products; contract manufacturing of therapeutics, supplements, and RNA delivery platforms

Downloadable software and mobile applications for use in the design, analysis, modelling, or optimisation of nucleic acid sequences, including RNA-based therapeutics; downloadable computer software for use in therapeutic delivery system design; downloadable computer software for bioinformatics, genetic analysis, and molecular diagnostics; downloadable databases and data management tools for drug discovery and personalised medicine; downloadable machine learning software for identifying and predicting therapeutic targets, molecular interactions, or genetic biomarkers; downloadable artificial intelligence software for bioinformatics, genetic analysis, and drug discovery; downloadable computer software for use in pharmaceutical research, formulation design, and RNA delivery platform development

Retail and wholesale store services featuring pharmaceuticals, biopharmaceuticals, dietary and nutritional supplements, medical devices, chemical substances and organic compounds for biotechnology and pharmaceutical use, laboratory reagents, diagnostic test kits, lipids and lipid-based formulations, plant-based supplements, vitamins, minerals, and other nutraceuticals; online retail store services in the field of biotechnology, diagnostics, and healthcare products featuring pharmaceutical and biotechnology products; retail store services featuring RNA-based therapeutics, delivery systems, and oligonucleotide products, namely mRNA and siRNA therapeutic products

Scientific and technological research in the fields of pharmaceuticals, biotechnology, and healthcare; pharmaceutical and biopharmaceutical research and development; development of mRNA-based therapeutics and vaccines; genetic and molecular biology research; scientific laboratory services for research and development in the fields of pharmaceuticals, biotechnology, and healthcare; laboratory testing and analysis; bioinformatics and computational biology, namely sequence alignment and genomic data analysis software services; AI-based drug discovery services, namely machine learning-based target identification services; genetic profiling for therapeutic purposes; design and testing of drug delivery systems and personalised medicine platforms; industrial research in the fields of pharmaceuticals, biotechnology, and healthcare; quality control of goods and services; technological consultancy in complex scientific fields, namely biotechnology and pharmaceutical development; consultancy pertaining to pharmacology and biotechnology; product research and development of dietary supplements and nutraceuticals; software as a service (SaaS) and platform services for the design, modelling, or optimisation of RNA sequences, delivery technologies, and therapeutic formulations; providing temporary use of online, non-downloadable computer software for use in therapeutic delivery system design; providing temporary use of online, non-downloadable computer software for bioinformatics, genetic analysis, and molecular diagnostics; providing temporary use of online, non-downloadable computer software for use in pharmaceutical research, formulation design, and RNA delivery platform development; processing and synthesis of nucleic acids, including mRNA and DNA, namely DNA and RNA screening services for scientific research purposes; research and development of biological substances and reagents; research and development of lipid and polymer-based drug delivery systems; research and development of organic substances, lipids, polymers, and excipients at the request of third parties; research and development of synthetic genes, oligonucleotides, chemically modified RNAs, polymer conjugates, and lipid-polymer complexes

Medical and diagnostic apparatus and instruments, namely biosensor-based diagnostic devices; injectors and drug delivery devices, namely needle-free injectors and autoinjector pens; wearable and implantable medical devices for administering pharmaceutical or gene therapy preparations; microneedle patches; transfection devices, namely electroporation-based transfection devices; medical diagnostic test kits for clinical and laboratory use, namely home-use test kits for blood glucose monitoring; apparatus for RNA-based therapeutic delivery, namely microneedle patch delivery apparatus; devices for personalised medicine and genetic diagnostics, namely genetic sequencing devices for personalised treatment planning; medical apparatus incorporating biosensors, nucleic acid detection systems, or AI-based diagnostic components, namely nucleic acid detection biosensor devices; devices for nucleic acid transfection and RNA delivery, namely lipid nanoparticle-based RNA delivery devices

Filing History

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 7, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 7, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 7, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 7, 2026 CNEA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 4, 2026 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 4, 2026 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 29, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 29, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 4, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 28, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 8, 2025 MAFR
NEW APPLICATION ENTERED
Sep 8, 2025 NWAP